FiercePharmaOriginal article
{"a":[{"_":"Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval ","$":{"href":"/pharma/lillys-onswik-set-broad-uk-coverage-after-pricing-authority-gives-ok","hreflang":"en"}}]}
RegulatoryapprovedOnswikPositive
AI Analysis
Summary
Lilly's Onswik, a long-acting weekly insulin for type 2 diabetes, received NICE approval for NHS coverage in the UK. The approval could allow hundreds of thousands of patients to reduce annual injections by 85%.
Outcome Details
NICE approved Onswik for NHS coverage in the UK
Importance:6/10
Sentiment:
0.80
insulintype 2 diabetesNICE approvalUK regulatoryweekly injection
Related Companies
Read the original article
Published by FiercePharma on August 19, 2026 3:17 PM